Eric Galia
9Patents
4h-index
35Co-inventors
53Inventor score
Filing activity: Mar 31, 2004 → Feb 21, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8383152B2 | Pharmaceutical dosage form | Emerging Cross-Sectional Technologies | 68 | Active |
| US9925146B2 | Oxidation-stabilized tamper-resistant dosage form | Human Necessities | 14 | Active |
| US9750701B2 | Pharmaceutical dosage form | Emerging Cross-Sectional Technologies | 12 | Active |
| US7205290B2 | Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use | Chemistry; Metallurgy | 5 | Expired |
| US10064945B2 | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc | Human Necessities | 1 | Active |
| US10363228B2 | Transdermal administration of memantine | Human Necessities | 1 | Active |
| US10493033B2 | Oxidation-stabilized tamper-resistant dosage form | Human Necessities | 0 | Active |
| US10080721B2 | Hot-melt extruded pharmaceutical dosage form | Human Necessities | 0 | Active |
| US7772429B2 | Diphenylazetidinone with improved physiological properties, process for its preparation, medicaments comprising this compound, and its use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.